FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149308066> ?p ?o ?g. }

• W2149308066 endingPage "74" @default.
• W2149308066 startingPage "69" @default.
• W2149308066 abstract "Objective Randomized controlled trial evaluating a topical treatment for cervical intraepithelial neoplasia 2 and 3 (CIN 2+) using cidofovir. Methods Fifty-three women with a biopsy-proven CIN 2+ were randomly assigned, 6 weeks before their planned conisation, either 3 applications of 3 ml 2% cidofovir in Intrasite® gel in a cervical cap or a placebo (the same volume of Intrasite® alone). A cervical sample for high-risk types of human papillomaviruses (HPV) (Hybrid Capture 2 or HC2) was taken before treatment and before conisation. The cone was submitted for pathological examination, and subsequently, along with the initial biopsy, to in situ hybridization (ISH) for high-risk HPV. Results Forty-eight patients were treated and followed according to the protocol, (23 cidofovir, and 25 placebo). Fourteen of the 23 cones were free of any CIN (60.8%) in the cidofovir group. Only 5 of 25 cones were free of any CIN (20%) in the placebo group (p<0.01). The difference remained significant in the ITT group (p<0.05). In the per-protocol and ITT populations, we observed more frequent viral clearance in the cidofovir group, but the difference was significant only when evaluated by ISH and not by HC2. No systemic toxicity was observed. Cervico-vaginal side effects of cidofovir were limited, and not statistically different from placebo. Conclusion The medical topical treatment with cidofovir, at this point, cannot replace conisation, but it is a promising candidate for topical chemotherapy of CIN 2+ lesions; a larger prospective randomized study is needed to confirm our results." @default.
• W2149308066 created "2016-06-24" @default.
• W2149308066 creator A5015861386 @default.
• W2149308066 creator A5025224681 @default.
• W2149308066 creator A5025872679 @default.
• W2149308066 creator A5034542365 @default.
• W2149308066 creator A5041860565 @default.
• W2149308066 creator A5046997637 @default.
• W2149308066 creator A5053353324 @default.
• W2149308066 creator A5059241712 @default.
• W2149308066 creator A5085228034 @default.
• W2149308066 creator A5088253246 @default.
• W2149308066 date "2009-10-01" @default.
• W2149308066 modified "2023-10-16" @default.
• W2149308066 title "Topical treatment of CIN 2+ by cidofovir: Results of a phase II, double-blind, prospective, placebo-controlled study" @default.
• W2149308066 cites W1990155825 @default.
• W2149308066 cites W1993058353 @default.
• W2149308066 cites W2004785370 @default.
• W2149308066 cites W2005382621 @default.
• W2149308066 cites W2010848574 @default.
• W2149308066 cites W2016175367 @default.
• W2149308066 cites W2022525353 @default.
• W2149308066 cites W2023210068 @default.
• W2149308066 cites W2033483460 @default.
• W2149308066 cites W2041694981 @default.
• W2149308066 cites W2060849266 @default.
• W2149308066 cites W2062691091 @default.
• W2149308066 cites W2068295925 @default.
• W2149308066 cites W2073934456 @default.
• W2149308066 cites W2077187240 @default.
• W2149308066 cites W2079395660 @default.
• W2149308066 cites W2085481899 @default.
• W2149308066 cites W2088357580 @default.
• W2149308066 cites W2125682256 @default.
• W2149308066 cites W2146188354 @default.
• W2149308066 cites W2164940564 @default.
• W2149308066 cites W2165384130 @default.
• W2149308066 cites W2168652503 @default.
• W2149308066 cites W2408222727 @default.
• W2149308066 doi "https://doi.org/10.1016/j.ygyno.2009.06.042" @default.
• W2149308066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19647859" @default.
• W2149308066 hasPublicationYear "2009" @default.
• W2149308066 type Work @default.
• W2149308066 sameAs 2149308066 @default.
• W2149308066 citedByCount "55" @default.
• W2149308066 countsByYear W21493080662012 @default.
• W2149308066 countsByYear W21493080662013 @default.
• W2149308066 countsByYear W21493080662014 @default.
• W2149308066 countsByYear W21493080662015 @default.
• W2149308066 countsByYear W21493080662016 @default.
• W2149308066 countsByYear W21493080662017 @default.
• W2149308066 countsByYear W21493080662018 @default.
• W2149308066 countsByYear W21493080662019 @default.
• W2149308066 countsByYear W21493080662020 @default.
• W2149308066 countsByYear W21493080662021 @default.
• W2149308066 countsByYear W21493080662022 @default.
• W2149308066 countsByYear W21493080662023 @default.
• W2149308066 crossrefType "journal-article" @default.
• W2149308066 hasAuthorship W2149308066A5015861386 @default.
• W2149308066 hasAuthorship W2149308066A5025224681 @default.
• W2149308066 hasAuthorship W2149308066A5025872679 @default.
• W2149308066 hasAuthorship W2149308066A5034542365 @default.
• W2149308066 hasAuthorship W2149308066A5041860565 @default.
• W2149308066 hasAuthorship W2149308066A5046997637 @default.
• W2149308066 hasAuthorship W2149308066A5053353324 @default.
• W2149308066 hasAuthorship W2149308066A5059241712 @default.
• W2149308066 hasAuthorship W2149308066A5085228034 @default.
• W2149308066 hasAuthorship W2149308066A5088253246 @default.
• W2149308066 hasConcept C121608353 @default.
• W2149308066 hasConcept C126322002 @default.
• W2149308066 hasConcept C126894567 @default.
• W2149308066 hasConcept C141071460 @default.
• W2149308066 hasConcept C142724271 @default.
• W2149308066 hasConcept C159047783 @default.
• W2149308066 hasConcept C168563851 @default.
• W2149308066 hasConcept C188816634 @default.
• W2149308066 hasConcept C204787440 @default.
• W2149308066 hasConcept C2522874641 @default.
• W2149308066 hasConcept C27081682 @default.
• W2149308066 hasConcept C2775934546 @default.
• W2149308066 hasConcept C2776824251 @default.
• W2149308066 hasConcept C2777343196 @default.
• W2149308066 hasConcept C2778220009 @default.
• W2149308066 hasConcept C71924100 @default.
• W2149308066 hasConcept C90924648 @default.
• W2149308066 hasConceptScore W2149308066C121608353 @default.
• W2149308066 hasConceptScore W2149308066C126322002 @default.
• W2149308066 hasConceptScore W2149308066C126894567 @default.
• W2149308066 hasConceptScore W2149308066C141071460 @default.
• W2149308066 hasConceptScore W2149308066C142724271 @default.
• W2149308066 hasConceptScore W2149308066C159047783 @default.
• W2149308066 hasConceptScore W2149308066C168563851 @default.
• W2149308066 hasConceptScore W2149308066C188816634 @default.
• W2149308066 hasConceptScore W2149308066C204787440 @default.
• W2149308066 hasConceptScore W2149308066C2522874641 @default.
• W2149308066 hasConceptScore W2149308066C27081682 @default.
• W2149308066 hasConceptScore W2149308066C2775934546 @default.
• W2149308066 hasConceptScore W2149308066C2776824251 @default.

• next